- Home
- ACVA vs TWST Comparison
ACVA vs TWST Comparison
Compare ACVA & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACVA
- TWST
- Stock Information
- Founded
- ACVA 2014
- TWST 2013
- Country
- ACVA United States
- TWST United States
- Employees
- ACVA N/A
- TWST N/A
- Industry
- ACVA Business Services
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACVA Consumer Discretionary
- TWST Health Care
- Exchange
- ACVA Nasdaq
- TWST Nasdaq
- Market Cap
- ACVA 2.7B
- TWST 2.3B
- IPO Year
- ACVA 2021
- TWST 2018
- Fundamental
- Price
- ACVA $12.15
- TWST $28.59
- Analyst Decision
- ACVA Strong Buy
- TWST Buy
- Analyst Count
- ACVA 13
- TWST 9
- Target Price
- ACVA $19.54
- TWST $50.67
- AVG Volume (30 Days)
- ACVA 2.9M
- TWST 2.0M
- Earning Date
- ACVA 08-11-2025
- TWST 08-04-2025
- Dividend Yield
- ACVA N/A
- TWST N/A
- EPS Growth
- ACVA N/A
- TWST N/A
- EPS
- ACVA N/A
- TWST N/A
- Revenue
- ACVA $707,243,000.00
- TWST $362,273,000.00
- Revenue This Year
- ACVA $23.10
- TWST $22.75
- Revenue Next Year
- ACVA $20.13
- TWST $17.63
- P/E Ratio
- ACVA N/A
- TWST N/A
- Revenue Growth
- ACVA 30.08
- TWST 22.72
- 52 Week Low
- ACVA $10.26
- TWST $24.28
- 52 Week High
- ACVA $23.46
- TWST $55.33
- Technical
- Relative Strength Index (RSI)
- ACVA 38.81
- TWST 43.88
- Support Level
- ACVA $11.17
- TWST $25.73
- Resistance Level
- ACVA $11.89
- TWST $29.71
- Average True Range (ATR)
- ACVA 0.57
- TWST 1.71
- MACD
- ACVA -0.03
- TWST 0.11
- Stochastic Oscillator
- ACVA 41.98
- TWST 62.28
About ACVA ACV Auctions Inc.
ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.